Breaking News
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
February 22, 2019 - U.S. opioid deaths jump fourfold in 20 years; epidemic shifts to Eastern states | News Center
February 22, 2019 - 5 Questions with William Turner on Diversity in Medicine
February 22, 2019 - HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
February 22, 2019 - Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer’s
February 22, 2019 - Biologist uses new grant to find ways to eliminate schistosomiasis
February 22, 2019 - Bag-mask ventilation to help patients breathe during intubation prevents complications
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials
February 22, 2019 - CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Family-history-based models perform better than non-family-history based models
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
February 22, 2019 - New blood test detects genetic disorders in fetuses
February 22, 2019 - Lower Self-Perception Observed in Children With Amblyopia
February 22, 2019 - Up to 15 percent of children have sleep apnea, yet 90 percent go undiagnosed
February 22, 2019 - Rare pulmonary defect prompts parents’ nationwide search for answers | News Center
February 22, 2019 - Lesbian and bisexual women at greater risk of being overweight, study finds
February 22, 2019 - UQ research may explain why vitamin D is essential for brain health
February 22, 2019 - Heart Attacks Rising Among Younger Women
February 22, 2019 - How your smartphone is affecting your relationship
February 22, 2019 - Orthopaedic surgeon receives prestigious award, $10 million grant | News Center
February 22, 2019 - New sepsis test could save thousands of lives
February 22, 2019 - Cervical cancer could be eradicated by 2100
February 21, 2019 - Sustained smoking cessation can lower risk of seropositive RA
February 21, 2019 - Thousands with chronic UTIs are not receiving the treatment they need
February 21, 2019 - Are teens getting high on social media? The surprising study seeking the pot-Instagram link
February 21, 2019 - Stanford expands biobank services | News Center
February 21, 2019 - Scientists identify link between drinking contexts and early onset intoxication among adolescents
February 21, 2019 - Strong social support may reduce cardiovascular disease risk in postmenopausal women
February 21, 2019 - Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years
February 21, 2019 - Motif Bio Receives Complete Response Letter From The FDA
February 21, 2019 - Researchers map previously unknown disease in children
February 21, 2019 - A skeptical look at popular diets: Going gluten-free
February 21, 2019 - Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
February 21, 2019 - Factors associated with increased risk of developing surgical site infections
February 21, 2019 - Anticipatory signals in eye movements can help measure attentive capacity, learning with greater precision
February 21, 2019 - Study explores daily exposure to indoor air pollutants
February 21, 2019 - Evening exercise does not negatively affect sleep, may also reduce hunger
February 21, 2019 - Artificial intelligence technique can be used to identify alcohol misuse in trauma setting
New weapons drawn in global TB fight

New weapons drawn in global TB fight

image_pdfDownload PDFimage_print
Last month UN member states agreed to a global plan to fight tuberculosis and allow cheaper access to vital drugs, such as bedaquiline, but estimate the cost of meeting the goal of ending the disease by 2030 at $13 billion annually

From a revolutionary way of testing children for tuberculosis to a cure for a previously untreatable strain, scientists from across the globe launched a fresh broadside Thursday against the world’s deadliest infectious disease.

Tuberculosis, a severe lung infection that is curable but historically hard to detect, kills more people each year than HIV/AIDS, and more than three times more than malaria.

Despite its potency—there were 1.7 million TB deaths in 2017 and certain strains are more deadly than Ebola—efforts to confront the disease have lagged behind those aimed at other communicable diseases.

More than 4,000 experts on lung health are gathering this week in The Hague and on Thursday they unveiled several new weapons in the battle against tuberculosis.

One potential game changer is a new method of testing children under five for the disease.

An estimated 240,000 children die from tuberculosis every year. The disease is curable and rarely deadly in infants if diagnosed and treated in time.

But as much as 90 percent of tuberculosis deaths in children are untreated cases.

The current test relies on the patient providing a sample of sputum—phlegm from the lower windpipe.

The sample is then analysed by a special machine, which then gives a result.

But as children under five cannot spit up sputum, doctors have to submit them to an invasive and painful procedure that often requires staying the night in hospital.

Researchers in Indonesia and Ethiopia found a way of testing children’s stool for the disease instead, meaning there would be no need for them to travel to a large health facility and they could be examined even in small villages or remote rural areas.

Petra de Haas, laboratory consultant at the KNCV Tuberculosis Foundation which developed the method, told AFP the test could save many of the 650 children who die of tuberculosis every day.

“This is a real breakthrough because this can be done in small laboratories,” she said.

Graphic on the global incidence of TB, including 558,000 multi-drug resistant cases in 2017

“We know already that a quarter of a million children die (every year). If they all got this test we could save at least half of them.”

New drug hope

“No child should die from TB,” said Jose Luis Castro, head of the International Union Against Tuberculosis and Lung Diseases.

“Promising breakthroughs of this kind are needed if we are to make inroads into preventing illness and death from tuberculosis.”

Scientists also unveiled the results of countrywide use of a new drug used to treat strains of tuberculosis that are resistant to most antibiotics, and therefore extremely difficult to kill.

Experts believe the strains are spreading worldwide due to poor handling of tuberculosis cases and has been noted by the World Health Organization in more than 100 countries.

A new drug, bedaquiline, has shown impressive results in countries such as Belarus, South Africa and Vietnam—all of which have high rates of multidrug-resistant TB.

Researchers Thursday that in Tajikistan, a former Soviet state where multidrug-resistant tuberculosis is widespread, 72 percent of patients given bedaquiline were either cured or completed their treatment.

In neighbouring Kyrgyzstan, the success rate was 74 percent.

Last month UN member states agreed to a global plan to fight tuberculosis and allow cheaper access to vital drugs, such as bedaquiline.

They put the cost of meeting the goal of ending tuberculosis by 2030 at $13 billion annually.

Angelina Grab, a nine-year-old tuberculosis survivor from South Africa, told AFP she was grateful for the advances already made in the battle against the killer disease.

“I remember I didn’t like having to take this bitter, disgusting medicine for half a year,” she said.

“But I knew if I didn’t take it I wouldn’t get better. I’m grateful for being this lucky and healthy now.”


Explore further:
‘Game changer’ tuberculosis drug cures 9 in 10

About author

Related Articles